Reaching an $894 million deal, drug giant Pfizer Inc has settled most of its lawsuits over the withdrawal of its pain reliever Bextra which has been linked to an elevated risk of heart attacks and strokes. Not having to pay as much as its rival, Merck & Co, Pfizer is planning on ending 92 percent of its law suits with this agreement.
To read the complete article click here.
Leave a comment